{"version":"company-facts.v1","source":"https://secwatch.observer","generated_at":"2026-06-07T13:01:06.831741+00:00","company":{"ticker":"LNTH","cik":1521036,"company_name":"Lantheus Holdings, Inc."},"pagination":{"limit":100,"returned":21,"next_cursor":null},"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer","facts":[{"fact_type":"earnings_release","fact_key":"e061550d8368e0377d54a5be2c1a8a3c71eb8ef0","cik":1521036,"ticker":"LNTH","company_name":"Lantheus Holdings, Inc.","filed_at":"2026-05-07T23:59:59+00:00","payload":{"eps_text":null,"guidance_signal":"reaffirmed","item_codes_triggered":["2.02"],"net_income_text":null,"period_text":"the three months ended March 31, 2026","report_date":"2026-05-07","result_type":"reported_results","revenue_text":null},"claim":"Lantheus Holdings, Inc. updated its the three months ended March 31, 2026 guidance (reaffirmed).","evidence_excerpt":"On May 7, 2026, Lantheus Holdings, Inc. (the “Company”) announced via press release its financial results as of and for the three months ended March 31, 2026. A copy of that press release is being furnished as Exhibit 99.1 and is hereby incorporated by reference.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001193125-26-210369","anchor_url":"https://secwatch.observer/filing/0001193125-26-210369#claim-e061550d8368e0377d54a5be2c1a8a3c71eb8ef0","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1521036/000119312526210369/0001193125-26-210369-index.htm"},{"fact_type":"governance_change","fact_key":"2e3e7dd5c8cbbb8172679c18ab2542260067133d","cik":1521036,"ticker":"LNTH","company_name":"Lantheus Holdings, Inc.","filed_at":"2026-05-01T23:59:59+00:00","payload":{"change_type":"charter_amendment","effective_date":"2026-04-30","item_codes_triggered":["5.03"],"summary_text":"Amended certificate of incorporation to declassify the Board of Directors over a three-year period and allow shareholder removal of directors with or without cause."},"claim":"Lantheus Holdings, Inc.: Amended certificate of incorporation to declassify the Board of Directors over a three-year period and allow shareholder removal of directors with or without cause (effective 2026-04-30).","evidence_excerpt":"On April 30, 2026, the Company filed a Certificate of Amendment (the “ Certificate of Amendment ”) to its Amended and Restated Certificate of Incorporation with the Secretary of State of the State of Delaware effecting an amendment to declassify the Company’s Board of Directors over a three-year period.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001193125-26-201556","anchor_url":"https://secwatch.observer/filing/0001193125-26-201556#claim-2e3e7dd5c8cbbb8172679c18ab2542260067133d","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1521036/000119312526201556/0001193125-26-201556-index.htm"},{"fact_type":"ma_transaction","fact_key":"e8710cf9e7a3ff60d9fcb84810b0e4e01513e361","cik":1521036,"ticker":"LNTH","company_name":"Lantheus Holdings, Inc.","filed_at":"2025-07-22T23:59:59+00:00","payload":{"action":"acquisition","closing_date":"2025-07-21","consideration_text":"$350 million","counterparty":"Life Medical Group Limited","effective_date":"2025-07-21","item_codes_triggered":["2.01"]},"claim":"Lantheus Holdings, Inc. completed an acquisition involving Life Medical Group Limited for $350 million (closed 2025-07-21).","evidence_excerpt":"the Transaction pursuant to the Agreement. In accordance with the Agreement, upon the closing of the Transaction, the Purchaser paid the Seller an upfront cash payment of $350 million (following applicable purchase price adjustments under the Agreement) in exchange for all of the outstanding share capital of Life Molecular. The foregoing description of the","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001193125-25-162233","anchor_url":"https://secwatch.observer/filing/0001193125-25-162233#claim-e8710cf9e7a3ff60d9fcb84810b0e4e01513e361","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1521036/000119312525162233/0001193125-25-162233-index.htm"},{"fact_type":"ma_transaction","fact_key":"bd5a21b2a1ec7b8f477a3385c66308dfd209e5fb","cik":1521036,"ticker":"LNTH","company_name":"Lantheus Holdings, Inc.","filed_at":"2025-04-01T23:59:59+00:00","payload":{"action":"acquisition","closing_date":"2025-04-01","consideration_text":"approximately $275 million in cash","counterparty":"Evergreen Theragnostics, Inc.","effective_date":"2025-04-01","item_codes_triggered":["2.01"]},"claim":"Lantheus Holdings, Inc. completed an acquisition involving Evergreen Theragnostics, Inc. for approximately $275 million in cash (closed 2025-04-01).","evidence_excerpt":"(CDMO) services as well as drug discovery and commercialization of proprietary products. In connection with the closing of the Merger, Lantheus Medical paid approximately $275 million in cash, subject to customary adjustments as set forth in the Merger Agreement, representing the $250 million upfront cash payment and a $25 million milestone payment in respect","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001193125-25-069927","anchor_url":"https://secwatch.observer/filing/0001193125-25-069927#claim-bd5a21b2a1ec7b8f477a3385c66308dfd209e5fb","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1521036/000119312525069927/0001193125-25-069927-index.htm"},{"fact_type":"executive_change","fact_key":"b86441aa40","cik":1521036,"ticker":"LNTH","company_name":"Lantheus Holdings, Inc.","filed_at":"2025-01-30T23:59:59+00:00","payload":{"action":"appointed","action_category":"appointment","departure_tone":"not_applicable","effective_date":"2025-01-29","interim":false,"role":"Director","role_category":"director","successor_name":null,"successor_named":false},"claim":"Phuong Khanh Morrow was appointed as Director at Lantheus Holdings, Inc..","evidence_excerpt":"On January 29, 2025, the board of directors of Lantheus Holdings, Inc. (the “Board”), upon the recommendation of the Nominating and Corporate Governance Committee, appointed Phuong Khanh (P.K.) Morrow, M.D., an experienced pharmaceutical executive and physician-scientist with deep expertise leading end-to-end clinical development in the field of oncology, to the Board.","confidence":1.0,"filing_url":"https://secwatch.observer/filing/0001193125-25-016381","anchor_url":"https://secwatch.observer/filing/0001193125-25-016381#claim-b86441aa40","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1521036/000119312525016381/0001193125-25-016381-index.htm"},{"fact_type":"executive_change","fact_key":"0e12a8b75d","cik":1521036,"ticker":"LNTH","company_name":"Lantheus Holdings, Inc.","filed_at":"2024-09-05T23:59:59+00:00","payload":{"action":"appointed","action_category":"appointment","departure_tone":"not_applicable","effective_date":"2024-09-03","interim":false,"role":"Director","role_category":"director","successor_name":null,"successor_named":false},"claim":"Julie Eastland was appointed as Director at Lantheus Holdings, Inc..","evidence_excerpt":"On September 3, 2024, the board of directors of Lantheus Holdings, Inc. (the “Board”), upon the recommendation of the Nominating and Corporate Governance Committee, appointed Julie Eastland, an experienced biotechnology and financial executive, to the Board.","confidence":1.0,"filing_url":"https://secwatch.observer/filing/0001193125-24-213726","anchor_url":"https://secwatch.observer/filing/0001193125-24-213726#claim-0e12a8b75d","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1521036/000119312524213726/0001193125-24-213726-index.htm"},{"fact_type":"executive_change","fact_key":"99fbc01a71","cik":1521036,"ticker":"LNTH","company_name":"Lantheus Holdings, Inc.","filed_at":"2024-06-24T23:59:59+00:00","payload":{"action":"will transition","action_category":"role_change","departure_tone":"routine","effective_date":"2024-08-01","interim":false,"role":"Chief Accounting Officer","role_category":"other_named_officer","successor_name":"Kimberly Brown","successor_named":true},"claim":"Andrea Sabens changed role as Chief Accounting Officer at Lantheus Holdings, Inc..","evidence_excerpt":"Andrea Sabens, the Company’s current Chief Accounting Officer and principal accounting officer, will transition to a new role at the Company and will no longer serve as the principal accounting officer as of the Effective Date.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001193125-24-167026","anchor_url":"https://secwatch.observer/filing/0001193125-24-167026#claim-99fbc01a71","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1521036/000119312524167026/0001193125-24-167026-index.htm"},{"fact_type":"executive_change","fact_key":"1685a41378","cik":1521036,"ticker":"LNTH","company_name":"Lantheus Holdings, Inc.","filed_at":"2024-06-24T23:59:59+00:00","payload":{"action":"appointed","action_category":"appointment","departure_tone":"not_applicable","effective_date":"2024-07-01","interim":false,"role":"Chief Accounting Officer","role_category":"other_named_officer","successor_name":null,"successor_named":false},"claim":"Kimberly Brown was appointed as Chief Accounting Officer at Lantheus Holdings, Inc..","evidence_excerpt":"On June 17, 2024, Kimberly Brown was appointed as the Chief Accounting Officer of Lantheus Holdings, Inc. (the “Company”) and its subsidiaries, effective July 1, 2024.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001193125-24-167026","anchor_url":"https://secwatch.observer/filing/0001193125-24-167026#claim-1685a41378","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1521036/000119312524167026/0001193125-24-167026-index.htm"},{"fact_type":"executive_change","fact_key":"238f794c99","cik":1521036,"ticker":"LNTH","company_name":"Lantheus Holdings, Inc.","filed_at":"2024-05-15T23:59:59+00:00","payload":{"action":"appointed","action_category":"role_change","departure_tone":"not_applicable","effective_date":"2024-05-28","interim":false,"role":"Chief Science Officer","role_category":"other_named_officer","successor_name":null,"successor_named":false},"claim":"Jean-Claude Provost was appointed as Chief Science Officer at Lantheus Holdings, Inc..","evidence_excerpt":"On May 15, 2024, Lantheus Holdings, Inc. (the “Company”) announced that, upon the effectiveness of his appointment as Chief Science Officer of the Company on May 28, 2024, Jean-Claude Provost MD will no longer serve as the Company’s Chief Medical Officer.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001193125-24-139440","anchor_url":"https://secwatch.observer/filing/0001193125-24-139440#claim-238f794c99","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1521036/000119312524139440/0001193125-24-139440-index.htm"},{"fact_type":"earnings_release","fact_key":"4a7cc452d17cc082344209786b3f2641afa487ed","cik":1521036,"ticker":"LNTH","company_name":"Lantheus Holdings, Inc.","filed_at":"2024-05-02T23:59:59+00:00","payload":{"eps_text":"$1.87","guidance_signal":"raised","item_codes_triggered":["2.02"],"net_income_text":"$131.1 million","period_text":"first quarter ended March 31, 2024","report_date":"2024-05-02","result_type":"reported_results","revenue_text":"$370.0 million"},"claim":"Lantheus Holdings, Inc. reported first quarter ended March 31, 2024 results: revenue $370.0 million, net income $131.1 million, EPS $1.87. Guidance raised.","evidence_excerpt":"Lantheus Reports First Quarter 2024 Financial Results First Quarter 2024 • Worldwide revenue of $370.0 million, an increase of 23.0% from first quarter 2023 • GAAP fully diluted net income per share of $1.87, compared to GAAP fully diluted net loss per share of $0.04 in first quarter 2023. Adjusted fully diluted net income per share of $1.69 compared to adjusted fully diluted net income per share of $1.47 in the first quarter 2023 • The Company increases full year 2024 net revenue and earnings guidance and provides guidance for the second quarter 2024","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001628280-24-019794","anchor_url":"https://secwatch.observer/filing/0001628280-24-019794#claim-4a7cc452d17cc082344209786b3f2641afa487ed","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1521036/000162828024019794/0001628280-24-019794-index.htm"},{"fact_type":"shareholder_vote","fact_key":"9fb6091acd8ce5cc1254090b7da48affdf8414cd","cik":1521036,"ticker":"LNTH","company_name":"Lantheus Holdings, Inc.","filed_at":"2024-04-29T23:59:59+00:00","payload":{"item_codes_triggered":["5.07"],"meeting_date":"2024-04-25","outcome":"passed","proposal_text":"Ratification of Appointment of Deloitte & Touche LLP","proposal_type":"auditor_ratification","results":[{"broker_non_votes":"0","subject":null,"votes_abstain":"87,441.00","votes_against":"521,644.00","votes_for":"62,428,177.56","votes_withheld":null}]},"claim":"Lantheus Holdings, Inc. shareholders approved Ratification of Appointment of Deloitte & Touche LLP at the 2024-04-25 meeting.","evidence_excerpt":"The appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2024 was ratified by the Company’s stockholders based on the following vote: Votes For Votes Against Abstentions Broker Non-Votes 62,428,177.56 521,644.00 87,441.00 0","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001193125-24-122683","anchor_url":"https://secwatch.observer/filing/0001193125-24-122683#claim-9fb6091acd8ce5cc1254090b7da48affdf8414cd","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1521036/000119312524122683/0001193125-24-122683-index.htm"},{"fact_type":"shareholder_vote","fact_key":"11886890ce557944a9c89a66924b0a1a26dc3f78","cik":1521036,"ticker":"LNTH","company_name":"Lantheus Holdings, Inc.","filed_at":"2024-04-29T23:59:59+00:00","payload":{"item_codes_triggered":["5.07"],"meeting_date":"2024-04-25","outcome":"passed","proposal_text":"Approval of an amendment to Lantheus Holdings, Inc. 2015 Equity Incentive Plan to increase the number of shares of common stock reserved for issuance thereunder by 4,000,000 shares","proposal_type":"equity_plan","results":[{"broker_non_votes":"4,929,820.86","subject":null,"votes_abstain":"109,627.00","votes_against":"3,335,696.04","votes_for":"54,662,118.66","votes_withheld":null}]},"claim":"Lantheus Holdings, Inc. shareholders approved Approval of an amendment to Lantheus Holdings, Inc. 2015 Equity Incentive Plan to increase the number of shares of common stock reserved for issuance thereunder by 4,000,000 shares at the 2024-04-25 meeting.","evidence_excerpt":"The approval of an amendment to the Lantheus Holdings, Inc. 2015 Equity Incentive Plan to increase the number of shares of common stock reserved for issuance thereunder by 4,000,000 shares was approved by the Company’s stockholders based on the following vote: Votes For Votes Against Abstentions Broker Non-Votes 54,662,118.66 3,335,696.04 109,627.00 4,929,820.86","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001193125-24-122683","anchor_url":"https://secwatch.observer/filing/0001193125-24-122683#claim-11886890ce557944a9c89a66924b0a1a26dc3f78","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1521036/000119312524122683/0001193125-24-122683-index.htm"},{"fact_type":"shareholder_vote","fact_key":"9216b409333c195d7f50d3b56a918a44deb19152","cik":1521036,"ticker":"LNTH","company_name":"Lantheus Holdings, Inc.","filed_at":"2024-04-29T23:59:59+00:00","payload":{"item_codes_triggered":["5.07"],"meeting_date":"2024-04-25","outcome":"passed","proposal_text":"Approval, on an advisory basis, of the compensation paid to our named executive officers","proposal_type":"say_on_pay","results":[{"broker_non_votes":"4,929,820.86","subject":null,"votes_abstain":"124,439.00","votes_against":"1,349,898.04","votes_for":"56,633,104.66","votes_withheld":null}]},"claim":"Lantheus Holdings, Inc. shareholders approved Approval, on an advisory basis, of the compensation paid to our named executive officers at the 2024-04-25 meeting.","evidence_excerpt":"The approval, on an advisory basis, of the compensation paid to our named executive officers was approved by the Company’s stockholders based on the following vote: Votes For Votes Against Abstentions Broker Non-Votes 56,633,104.66 1,349,898.04 124,439.00 4,929,820.86","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001193125-24-122683","anchor_url":"https://secwatch.observer/filing/0001193125-24-122683#claim-9216b409333c195d7f50d3b56a918a44deb19152","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1521036/000119312524122683/0001193125-24-122683-index.htm"},{"fact_type":"shareholder_vote","fact_key":"3f1142d6e205af5905854939f44b7f66b4a1fabf","cik":1521036,"ticker":"LNTH","company_name":"Lantheus Holdings, Inc.","filed_at":"2024-04-29T23:59:59+00:00","payload":{"item_codes_triggered":["5.07"],"meeting_date":"2024-04-25","outcome":"passed","proposal_text":"Election of Directors","proposal_type":"director_election","results":[{"broker_non_votes":"4,929,820.86","subject":"Brian Markison","votes_abstain":"84,921.00","votes_against":"2,972,256.00","votes_for":"55,050,264.70","votes_withheld":null},{"broker_non_votes":"4,929,820.86","subject":"Gary Pruden","votes_abstain":"85,277.00","votes_against":"4,674,902.00","votes_for":"53,347,262.70","votes_withheld":null},{"broker_non_votes":"4,929,820.86","subject":"Dr. James H. Thrall","votes_abstain":"139,135.00","votes_against":"20,017,407.14","votes_for":"37,950,899.56","votes_withheld":null}]},"claim":"Lantheus Holdings, Inc. shareholders approved Election of Directors at the 2024-04-25 meeting.","evidence_excerpt":"Nominee Votes For Votes Against Abstentions Broker Non-Votes Brian Markison 55,050,264.70 2,972,256.00 84,921.00 4,929,820.86 Gary Pruden 53,347,262.70 4,674,902.00 85,277.00 4,929,820.86 Dr. James H. Thrall 37,950,899.56 20,017,407.14 139,135.00 4,929,820.86","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001193125-24-122683","anchor_url":"https://secwatch.observer/filing/0001193125-24-122683#claim-3f1142d6e205af5905854939f44b7f66b4a1fabf","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1521036/000119312524122683/0001193125-24-122683-index.htm"},{"fact_type":"earnings_release","fact_key":"0961bee8c2ce12b95ac7da65cd4708d318d552a4","cik":1521036,"ticker":"LNTH","company_name":"Lantheus Holdings, Inc.","filed_at":"2024-02-22T23:59:59+00:00","payload":{"eps_text":"$1.47 and $4.65 per fully diluted share","guidance_signal":"initiated","item_codes_triggered":["2.02"],"net_income_text":"$103.4 million and $326.7 million","period_text":"the fourth quarter and full year ended December 31, 2023","report_date":"2024-02-22","result_type":"reported_results","revenue_text":"$354.0 million and $1.3 billion"},"claim":"Lantheus Holdings, Inc. reported the fourth quarter and full year ended December 31, 2023 results: revenue $354.0 million and $1.3 billion, net income $103.4 million and $326.7 million, EPS $1.47 and $4.65 per fully diluted share. Guidance initiated.","evidence_excerpt":"Lantheus Reports Fourth Quarter and Full Year 2023 Financial Results • Worldwide revenue of $354.0 million and $1.3 billion for the fourth quarter and full year 2023 • GAAP net income of $103.4 million and $326.7 million for the fourth quarter and full year 2023 • GAAP fully diluted net income per share of $1.47 and $4.65 for the fourth quarter and full year 2023","confidence":0.97,"filing_url":"https://secwatch.observer/filing/0001628280-24-006157","anchor_url":"https://secwatch.observer/filing/0001628280-24-006157#claim-0961bee8c2ce12b95ac7da65cd4708d318d552a4","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1521036/000162828024006157/0001628280-24-006157-index.htm"},{"fact_type":"executive_change","fact_key":"76b50811ab","cik":1521036,"ticker":"LNTH","company_name":"Lantheus Holdings, Inc.","filed_at":"2024-01-23T23:59:59+00:00","payload":{"action":"appointed","action_category":"appointment","departure_tone":"not_applicable","effective_date":"2024-01-23","interim":false,"role":"Lead Independent Director","role_category":"other","successor_name":null,"successor_named":false},"claim":"Julie McHugh was appointed as Lead Independent Director at Lantheus Holdings, Inc..","evidence_excerpt":"the Board has appointed Julie McHugh as Lead Independent Director of the Board, effective January 23, 2024.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001193125-24-012605","anchor_url":"https://secwatch.observer/filing/0001193125-24-012605#claim-76b50811ab","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1521036/000119312524012605/0001193125-24-012605-index.htm"},{"fact_type":"executive_change","fact_key":"707fc07bb3","cik":1521036,"ticker":"LNTH","company_name":"Lantheus Holdings, Inc.","filed_at":"2024-01-23T23:59:59+00:00","payload":{"action":"appointed","action_category":"appointment","departure_tone":"not_applicable","effective_date":"2024-03-01","interim":false,"role":"Chief Executive Officer","role_category":"ceo","successor_name":null,"successor_named":false},"claim":"Brian Markison was appointed as Chief Executive Officer at Lantheus Holdings, Inc..","evidence_excerpt":"The Company has also announced that Brian Markison, the Chairman of the Board, has been appointed Executive Chairman as of January 23, 2024 to serve in that role until the Effective Date and will become the Company’s Chief Executive Officer effective on the Effective Date.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001193125-24-012605","anchor_url":"https://secwatch.observer/filing/0001193125-24-012605#claim-707fc07bb3","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1521036/000119312524012605/0001193125-24-012605-index.htm"},{"fact_type":"executive_change","fact_key":"34c49d311b","cik":1521036,"ticker":"LNTH","company_name":"Lantheus Holdings, Inc.","filed_at":"2024-01-23T23:59:59+00:00","payload":{"action":"appointed","action_category":"appointment","departure_tone":"not_applicable","effective_date":"2024-01-23","interim":true,"role":"Executive Chairman","role_category":"chair","successor_name":null,"successor_named":false},"claim":"Brian Markison was appointed as Executive Chairman at Lantheus Holdings, Inc..","evidence_excerpt":"The Company has also announced that Brian Markison, the Chairman of the Board, has been appointed Executive Chairman as of January 23, 2024 to serve in that role until the Effective Date and will become the Company’s Chief Executive Officer effective on the Effective Date.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001193125-24-012605","anchor_url":"https://secwatch.observer/filing/0001193125-24-012605#claim-34c49d311b","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1521036/000119312524012605/0001193125-24-012605-index.htm"},{"fact_type":"executive_change","fact_key":"64d0c81eaa","cik":1521036,"ticker":"LNTH","company_name":"Lantheus Holdings, Inc.","filed_at":"2024-01-23T23:59:59+00:00","payload":{"action":"appointed","action_category":"appointment","departure_tone":"not_applicable","effective_date":"2024-03-01","interim":false,"role":"Chair of the Board","role_category":"chair","successor_name":null,"successor_named":false},"claim":"Mary Anne Heino was appointed as Chair of the Board at Lantheus Holdings, Inc..","evidence_excerpt":"Ms. Heino will continue to serve as a member of the Board and has been appointed to serve as Chair of the Board as of the Effective Date.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001193125-24-012605","anchor_url":"https://secwatch.observer/filing/0001193125-24-012605#claim-64d0c81eaa","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1521036/000119312524012605/0001193125-24-012605-index.htm"},{"fact_type":"executive_change","fact_key":"9c9663e715","cik":1521036,"ticker":"LNTH","company_name":"Lantheus Holdings, Inc.","filed_at":"2024-01-23T23:59:59+00:00","payload":{"action":"retired","action_category":"departure","departure_tone":"retirement","effective_date":"2024-03-01","interim":false,"role":"Chief Executive Officer","role_category":"ceo","successor_name":"Brian Markison","successor_named":true},"claim":"Mary Anne Heino retired as Chief Executive Officer at Lantheus Holdings, Inc..","evidence_excerpt":"Mary Anne Heino, the Company’s Chief Executive Officer and a member of the Company’s board of directors (the “Board”), notified the Board on January 18, 2024, of her intention to retire as Chief Executive Officer, effective March 1, 2024","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001193125-24-012605","anchor_url":"https://secwatch.observer/filing/0001193125-24-012605#claim-9c9663e715","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1521036/000119312524012605/0001193125-24-012605-index.htm"},{"fact_type":"earnings_release","fact_key":"5525cacf85339ddc25841be18bb9f8cc5dd078f5","cik":1521036,"ticker":"LNTH","company_name":"Lantheus Holdings, Inc.","filed_at":"2024-01-09T23:59:59+00:00","payload":{"eps_text":null,"guidance_signal":"none","item_codes_triggered":["2.02"],"net_income_text":null,"period_text":"fiscal year ended December 31, 2023","report_date":"2024-01-09","result_type":"preliminary_results","revenue_text":"$1.295 - 1.297 billion"},"claim":"Lantheus Holdings, Inc. reported fiscal year ended December 31, 2023 results: revenue $1.295 - 1.297 billion.","evidence_excerpt":"Lantheus Reports Preliminary Fiscal Year 2023 Revenue Full year 2023 worldwide revenue expected to be in the range of $1.295 – 1.297 billion","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001628280-24-000888","anchor_url":"https://secwatch.observer/filing/0001628280-24-000888#claim-5525cacf85339ddc25841be18bb9f8cc5dd078f5","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1521036/000162828024000888/0001628280-24-000888-index.htm"}]}